Cite
HARVARD Citation
Olsson-Brown, A. et al. (2019). The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool. Breast. pp. 94-100. [Online].